AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Accelerated Rehabilitation in Individuals After Total Knee Arthroplasty

RecruitingNAAges 50 Years - 80 YearsAllMahidol University
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The primary aim of this double-blind randomized controlled trial is to evaluate the effectiveness of an accelerated rehabilitation protocol on knee joint function and quality of life in individuals undergoing TKA compared to conventional rehabilitation in Dali, Yunan, China. The study will include patients aged 50-80 years who are scheduled for primary unilateral TKA. Participants will be randomly assigned to either an accelerated rehabilitation group or conventional rehabilitation group. The primary outcomes will include knee joint function, assessed using the KOOS and quality of life measures using the SF-36 surveys. The study will follow participants for 6 months post-surgery to assess longer-term outcomes. This study will not include individuals undergoing revision TKA or those with severe comorbid conditions. The results will provide critical insights into the role of accelerated re

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Patients diagnosed with end-stage knee OA necessitating primary unilateral TKA. Exclusion Criteria: * History of joint infections, cancer, or inflammatory arthritis. * End-stage OA from rheumatoid or septic arthritis. * Individuals with neurological disorders such as Alzheimer's disease, - Parkinson's disease, stroke. * Individuals who are unable to follow a structured rehabilitation protocol. * Previous history of knee surgeries (other than arthroscopy). * Severe comorbidities that would hinder participation (e.g., advanced cardiovascular diseases). * Individuals who have severe osteoporosis.
๐Ÿ’Š

What it tests

  • Accelerated exercise
  • Routine exercise
๐Ÿ“

Where

1 site
Hospital
Dali, China
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy